one-color microarray-based gene expression analysis (Agilent technologies)
Agilent technologies is a verified supplier 
Agilent technologies manufactures this product 
90
Structured Review
Agilent technologies
one-color microarray-based gene expression analysis
One Color Microarray Based Gene Expression Analysis, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+microarray+analysis/pm39074525-318-4-1
Average 90 stars, based on 1 article reviews
One Color Microarray Based Gene Expression Analysis, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+microarray+analysis/pm39074525-318-4-1
Average 90 stars, based on 1 article reviews
one-color microarray-based gene expression analysis - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Expressing:Article Title: Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Article Snippet: Approximately 25,000 ovarian cancers are diagnosed in the US annually, and 75% of cases are in the advanced stage when they are largely incurable.. There is a critical need for improved early detection tools and development of novel treatments.. Because chromosome band 20q13 is a commonly DNA amplified region in ovarian cancer and increase in 20q13 copy number may be an early event, we examined the DNA amplification and RNA expression pattern of 239 microarray probes mapping to this region with the goal of identifying gene(s) associated with ovarian cancer. Article Title: Synaptogyrin-2 Promotes Replication of a Novel Tick-borne Bunyavirus through Interacting with Viral Nonstructural Protein NSs Article Snippet: .. To further decipher the mechanism by which NSs may transform lipid droplets and whether there are cellular proteins that are involved in the process, we sought to profile global gene expression and screen potential host genes regulated in SFTSV-infected HepG2 cells with an Article Title: Periostin promotes ovarian cancer angiogenesis and metastasis. Article Snippet: a Division of Hematology-Oncology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA b Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA, USA c Department of Biological Chemistry, University of California at Los Angeles, Los Angeles, CA, USA d Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA e Division of Gynecological Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA Microarray:Article Title: Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Article Snippet: Approximately 25,000 ovarian cancers are diagnosed in the US annually, and 75% of cases are in the advanced stage when they are largely incurable.. There is a critical need for improved early detection tools and development of novel treatments.. Because chromosome band 20q13 is a commonly DNA amplified region in ovarian cancer and increase in 20q13 copy number may be an early event, we examined the DNA amplification and RNA expression pattern of 239 microarray probes mapping to this region with the goal of identifying gene(s) associated with ovarian cancer. Article Title: Synaptogyrin-2 Promotes Replication of a Novel Tick-borne Bunyavirus through Interacting with Viral Nonstructural Protein NSs Article Snippet: .. To further decipher the mechanism by which NSs may transform lipid droplets and whether there are cellular proteins that are involved in the process, we sought to profile global gene expression and screen potential host genes regulated in SFTSV-infected HepG2 cells with an Article Title: Periostin promotes ovarian cancer angiogenesis and metastasis. Article Snippet: a Division of Hematology-Oncology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA b Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA, USA c Department of Biological Chemistry, University of California at Los Angeles, Los Angeles, CA, USA d Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA e Division of Gynecological Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA Fluorescence:Article Title: Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Article Snippet: Approximately 25,000 ovarian cancers are diagnosed in the US annually, and 75% of cases are in the advanced stage when they are largely incurable.. There is a critical need for improved early detection tools and development of novel treatments.. Because chromosome band 20q13 is a commonly DNA amplified region in ovarian cancer and increase in 20q13 copy number may be an early event, we examined the DNA amplification and RNA expression pattern of 239 microarray probes mapping to this region with the goal of identifying gene(s) associated with ovarian cancer. In Situ Hybridization:Article Title: Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Article Snippet: Approximately 25,000 ovarian cancers are diagnosed in the US annually, and 75% of cases are in the advanced stage when they are largely incurable.. There is a critical need for improved early detection tools and development of novel treatments.. Because chromosome band 20q13 is a commonly DNA amplified region in ovarian cancer and increase in 20q13 copy number may be an early event, we examined the DNA amplification and RNA expression pattern of 239 microarray probes mapping to this region with the goal of identifying gene(s) associated with ovarian cancer. Fluorescence In Situ Hybridization:Article Title: Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Article Snippet: Approximately 25,000 ovarian cancers are diagnosed in the US annually, and 75% of cases are in the advanced stage when they are largely incurable.. There is a critical need for improved early detection tools and development of novel treatments.. Because chromosome band 20q13 is a commonly DNA amplified region in ovarian cancer and increase in 20q13 copy number may be an early event, we examined the DNA amplification and RNA expression pattern of 239 microarray probes mapping to this region with the goal of identifying gene(s) associated with ovarian cancer. Immunohistochemistry:Article Title: Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Article Snippet: Approximately 25,000 ovarian cancers are diagnosed in the US annually, and 75% of cases are in the advanced stage when they are largely incurable.. There is a critical need for improved early detection tools and development of novel treatments.. Because chromosome band 20q13 is a commonly DNA amplified region in ovarian cancer and increase in 20q13 copy number may be an early event, we examined the DNA amplification and RNA expression pattern of 239 microarray probes mapping to this region with the goal of identifying gene(s) associated with ovarian cancer. Article Title: Periostin promotes ovarian cancer angiogenesis and metastasis. Article Snippet: a Division of Hematology-Oncology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA b Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA, USA c Department of Biological Chemistry, University of California at Los Angeles, Los Angeles, CA, USA d Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA e Division of Gynecological Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA Gene Expression:Article Title: Synaptogyrin-2 Promotes Replication of a Novel Tick-borne Bunyavirus through Interacting with Viral Nonstructural Protein NSs Article Snippet: .. To further decipher the mechanism by which NSs may transform lipid droplets and whether there are cellular proteins that are involved in the process, we sought to profile global gene expression and screen potential host genes regulated in SFTSV-infected HepG2 cells with an Amplification:Article Title: Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Article Snippet: Approximately 25,000 ovarian cancers are diagnosed in the US annually, and 75% of cases are in the advanced stage when they are largely incurable.. There is a critical need for improved early detection tools and development of novel treatments.. Because chromosome band 20q13 is a commonly DNA amplified region in ovarian cancer and increase in 20q13 copy number may be an early event, we examined the DNA amplification and RNA expression pattern of 239 microarray probes mapping to this region with the goal of identifying gene(s) associated with ovarian cancer. Northern Blot:Article Title: Periostin promotes ovarian cancer angiogenesis and metastasis. Article Snippet: a Division of Hematology-Oncology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA b Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA, USA c Department of Biological Chemistry, University of California at Los Angeles, Los Angeles, CA, USA d Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA e Division of Gynecological Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA |
